Beyond Rheumatoid Arthritis Evaluation: What are We Missing?

References

• Albayrak Gezer İ, Balkarli A, Can B, Bağçaci S, Küçükşen S, Küçük A. Pain, depression levels, fatigue, sleep quality, and quality of life in elderly patients with rheumatoid arthritis. Turkish J Med Sci. 2017;47(3):847–853. doi:10.3906/sag-1603-147
   Web of Science ®Google Scholar
• Littlejohn EA, Monrad SU, Diagnosis E. Treatment of Rheumatoid Arthritis. Prim Care - Clin off Pract. 2018;45(2):237–255. doi:10.1016/j.pop.2018.02.010
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038. doi:10.1016/S0140-6736(16)30173-8
   PubMed Web of Science ®Google Scholar
• Shim E-J, Song YW, Park S-H, Lee K-M, Go DJ, Hahm B-J. Examining the relationship between pain catastrophizing and suicide risk in patients with rheumatic disease: the mediating role of depression, perceived social support, and perceived burdensomeness. Int J Behav Med. 2017;24(4):501–512. doi:10.1007/s12529-017-9648-1
   PubMed Web of Science ®Google Scholar
• Fiest KM, Hitchon CA, Bernstein CN, et al. Systematic review and meta-analysis of interventions for depression and anxiety in persons with rheumatoid arthritis. J Clin Rheumatol. 2017;23:425–434. doi:10.1097/RHU.0000000000000489
   PubMed Web of Science ®Google Scholar
• Beşirli A, Jö A, Kaymak D, Özer ÖA. The relationship between anxiety, depression, suicidal ideation and quality of life in patients with rheumatoid arthritis. Psychiatr Q. 2020;91(1):53–64. doi:10.1007/s11126-019-09680-x
   PubMed Web of Science ®Google Scholar
• Kim SY, Chanyang M, Oh DJ, Choi HG. Association between depression and rheumatoid arthritis: two longitudinal follow-up studies using a national sample cohort. Rheumatology. 2020;59(8):1889–1897. doi:10.1093/rheumatology/kez559
   PubMed Web of Science ®Google Scholar
• Žagar I, Delimar V, Pap M, Perić D, Žerjavić NL, Perić P. Prevalence and correlation of depressive symptoms with functional scores, therapy and disease activity among Croatian patients with rheumatoid arthritis: a preliminary study. Psychiatr Danub. 2018;30(4):452–458. doi:10.24869/psyd.2018.452
   Web of Science ®Google Scholar
• Vallerand IA, Patten SB, Barnabe C. Depression and the risk of rheumatoid arthritis. Curr Opin Rheumatol. 2019;31(3):279–284. doi:10.1097/BOR.0000000000000597
   PubMed Web of Science ®Google Scholar
• Sováriová Soósová M, Macejová Z, Zamboriová M, Dimunová L. Anxiety and depression in Slovak patients with rheumatoid arthritis. J Ment Heal. 2016;13(14):1–7.
   Google Scholar
• Ménard C, Hodes GE, Russo SJ. Pathogenesis of depression: insights from human and rodent studies. Neuroscience. 2016;321:138–162.
   PubMed Web of Science ®Google Scholar
• Hasan Davami M, Baharlou R, Ahmadi Vasmegjani A, et al. elevated IL-17 and TGF-β serum levels: a positive correlation between T-helper 17 cell-related pro-inflammatory responses with major depressive disorder. Basic Clin Neurosci. 2016;7(2):137–142. doi:10.15412/J.BCN.03070207
   Google Scholar
• Nerurkar L, Siebert S, McInnes IB, Cavanagh J. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry. 2019;6(2):164–173. doi:10.1016/S2215-0366(18)30255-4
   PubMed Web of Science ®Google Scholar
• Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013;52(12):2136–2148. doi:10.1093/rheumatology/ket169
   PubMed Web of Science ®Google Scholar
• Sturgeon JA, Finan PH, Zautra AJ. Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nat Rev Rheumatol. 2016;12(9):532–542. doi:10.1038/nrrheum.2016.112
   Web of Science ®Google Scholar
• Withers MH, Gonzalez LT, Karpouzas GA. Identification and treatment optimization of comorbid depression in rheumatoid arthritis. Rheumatol Ther. 2017;4(2):281–291. doi:10.1007/s40744-017-0072-4
   Web of Science ®Google Scholar
• Li Y-C, Chou Y-C, Chen H-C, Lu C-C, Chang D-M. Interleukin-6 and interleukin-17 are related to depression in patients with rheumatoid arthritis. Int J Rheum Dis. 2019;22(6):980–985. doi:10.1111/1756-185X.13529
   PubMed Web of Science ®Google Scholar
• Zhang L, Cai P, Zhu W. Depression has an impact on disease activity and health‐related quality of life in rheumatoid arthritis: a systematic review and meta‐analysis. Int J Rheum Dis. 2020;23(3):285–293. doi:10.1111/1756-185X.13774
   PubMed Web of Science ®Google Scholar
• Intriago M, Maldonado G, Cardenas J, Rios C. Quality of life in Ecuadorian patients with established rheumatoid arthritis. Open Access Rheumatol Res Rev. 2019;11:199–205.
   Web of Science ®Google Scholar
• Peterson S, Piercy J, Blackburn S, Sullivan E, Karyekar CS, Li N. The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis. BMC Rheumatol. 2019;3(1):1–10. doi:10.1186/s41927-019-0092-5
   Google Scholar
• Abdel-Ahad P, El Chammai M, Fneich A, Issa R, Kabbara W, Richa S. Psychiatric aspects of rheumatoid arthritis: review of literature. Encephale. 2016;42(2):172–176. doi:10.1016/j.encep.2015.12.008
   Web of Science ®Google Scholar
• Imran MY, Khan SEA, Ahmad NM, Raja SF, Saeed MA, Haider II. Depression in rheumatoid arthritis and its relation to disease activity. Pakistan J Med Sci. 2015;31(2):393–397.
   PubMed Web of Science ®Google Scholar
• Sleath B, Chewning B, De Vellis BM, et al. Communication about depression during rheumatoid arthritis patient visits. Arthritis Care Res. 2008;59(2):186–191. doi:10.1002/art.23347
   Web of Science ®Google Scholar
• Calandre EP, Rico-Villademoros F, Slim M. Suicidal behaviors in patients with rheumatic diseases: a narrative review. Rheumatol Int. 2018;38(4):537–548. doi:10.1007/s00296-017-3909-9
   Web of Science ®Google Scholar
• Marrie RA, Walld R, Bolton JM, et al. Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases. Gen Hosp Psychiatry. 2018;53(06):65–72. doi:10.1016/j.genhosppsych.2018.06.001
   Web of Science ®Google Scholar
• Kuriya B, Vigod S, Luo J, Widdifield J, Haroon N. The risk of deliberate self-harm following a diagnosis of rheumatoid arthritis or ankylosing spondylitis: a population-based cohort study. PLoS One. 2020;15(2):1–14. doi:10.1371/journal.pone.0229273
   Web of Science ®Google Scholar
• Treharne GJ, Lyons AC, Kitas GD. Suicidal ideation in patients with rheumatoid arthritis. RESEARCH May Help Identify Patients at High Risk. BMJ. 2000;321(7271):1290.
   Google Scholar
• Li Z, Yang Y, Dong C, et al. The prevalence of suicidal ideation and suicide attempt in patients with rheumatic diseases: a systematic review and meta-analysis. Psychol Heal Med. 2018;23(9):1025–1036. doi:10.1080/13548506.2018.1476724
   PubMed Web of Science ®Google Scholar
• Hewlett S, Hehir M, Kirwan JR. Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use. Arthritis Care Res. 2007;57(3):429–439. doi:10.1002/art.22611
   Web of Science ®Google Scholar
• Nicassio O, Ormseth S, Custodio M, et al. Model of Fatigue in Patients with Rheumatoid Arthritis. Bone. 2012;39(9):1807–1813.
   Google Scholar
• Repping-Wuts H, Van Riel P, Van Achterberg T. Fatigue in patients with rheumatoid arthritis: what is known and what is needed. Rheumatology. 2009;48(3):207–209. doi:10.1093/rheumatology/ken399
   Web of Science ®Google Scholar
• Nikolaus S, Bode C, Taal E, Van De Laar MAFJ. Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res. 2013;65(7):1128–1146. doi:10.1002/acr.21949
   Web of Science ®Google Scholar
• Irwin MR, Olmstead R, Carrillo C, et al. Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep. 2012;35(4):537–543. doi:10.5665/sleep.1742
   PubMed Web of Science ®Google Scholar
• Abdul-Rahim R, Hwee-Chen C. Self-reported symptoms of depression, anxiety and stress among patients with Rheumatoid Arthritis in a Malaysian rheumatology centre - prevalence and correlates. Med J Malaysia. 2018;73(4):226–232.
   Google Scholar
• Rezaei M, Khormali M, Akbarpour S, Sadeghniiat-Hagighi K, Shamsipour M. Sleep quality and its association with psychological distress and sleep hygiene: a cross-sectional study among pre-clinical medical students. Sleep Sci. 2018;11(4):274–280. doi:10.5935/1984-0063.20180043
   Web of Science ®Google Scholar
• Westhovens R, Van Der Elst K, Matthys A, Tran M, Gilloteau I. Sleep problems in patients with rheumatoid arthritis. J Rheumatol. 2014;41(1):31–40. doi:10.3899/jrheum.130430
   PubMed Web of Science ®Google Scholar
• Fenton SAM, van Zanten JJCSV, Duda JL, Metsios GS, Kitas GD. Sedentary behaviour in rheumatoid arthritis: definition, measurement and implications for health. Rheumatol (United Kingdom). 2018;57(2):213–226.
   Web of Science ®Google Scholar
• Wolfe F, Michaud K. Effect of body mass index on mortality and clinical status in rheumatoid arthritis. Arthritis Care Res. 2012;64(10):1471–1479. doi:10.1002/acr.21627
   PubMed Web of Science ®Google Scholar
• Challal S, Minichiello E, Boissier MC, Semerano L. Cachexia and adiposity in rheumatoid arthritis. Relevance for disease management and clinical outcomes. Rev Du Rhum (Edition Fr). 2016;83(1):19–25.
   Google Scholar
• Santo RCE, Fernandes KZ, Lora PS, Filippin LI, Xavier RM. Prevalence of rheumatoid cachexia in rheumatoid arthritis: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2018;9(5):816–825. doi:10.1002/jcsm.12320
   PubMed Web of Science ®Google Scholar
• Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum. 2004;50(11):3450–3457. doi:10.1002/art.20612
   PubMed Web of Science ®Google Scholar
• Book C, Karlsson MK, Åkesson K, Jacobsson LTH. Early rheumatoid arthritis and body composition. Rheumatology. 2009;48(9):1128–1132. doi:10.1093/rheumatology/kep165
   Web of Science ®Google Scholar
• Moroni L, Farina N, Dagna L. Obesity and its role in the management of rheumatoid and psoriatic arthritis. Clin Rheumatol. 2020;39(4):1039–1047. doi:10.1007/s10067-020-04963-2
   Web of Science ®Google Scholar
• Qin B, Yang M, Fu H, et al. Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis. Arthritis Res Ther. 2015;17(1):1–12. doi:10.1186/s13075-014-0514-0
   Web of Science ®Google Scholar
• Feng J, Chen Q, Yu F, et al. Body mass index and risk of rheumatoid arthritis a meta-analysis of observational studies. Med (United States). 2016;95(8):1–8.
   Google Scholar
• Lumeng CN, Saltiel AR. Review series Inflammatory links between obesity and metabolic disease. Life Sci. 2011;121(6):2111–2117.
   Google Scholar
• Kreps D, Halperin F, Desai S, et al. Association of weight loss with improved disease activity in patients with rheumatoid arthritis: a retrospective analysis using electronic medical record data. Int J Rheumatol. 2018;13(1):1–10.
   Google Scholar
• Ellerby N, Mattey DL, Packham J, Dawes P, Hider SL. Obesity and comorbidity are independently associated with a failure to achieve remission in patients with established rheumatoid arthritis. Ann Rheum Dis. 2014;73(11):1–3. doi:10.1136/annrheumdis-2014-206254
   Web of Science ®Google Scholar
• Sandberg MEC, Bengtsson C, Källberg H, et al. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis. Ann Rheum Dis. 2014;73(11):2029–2033. doi:10.1136/annrheumdis-2013-205094
   PubMed Web of Science ®Google Scholar
• Ajeganova S, Andersson ML, Hafström I. Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset. Arthritis Care Res. 2013;65(1):78–87. doi:10.1002/acr.21710
   Web of Science ®Google Scholar
• Passot C, Mulleman D, Bejan-Angoulvant T, et al. The underlying inflammatory chronic disease influences infliximab pharmacokinetics. MAbs. 2016;8(7):1407–1416. doi:10.1080/19420862.2016.1216741
   PubMed Web of Science ®Google Scholar
• Kaeley GS, MacCarter DK, Pangan AL, Wang X, Kalabic J, Ranganath VK. Clinical responses and synovial vascularity in obese rheumatoid arthritis patients treated with adalimumab and methotrexate. J Rheumatol. 2018;45(12):1628–1635. doi:10.3899/jrheum.171232
   Web of Science ®Google Scholar
• Bazzichi L, Giacomelli C, Consensi A, et al. Review One year in review: fibromyalgia. Clin Exp Rheumatol. 2016;34(96):S145–149.
   Google Scholar
• Provan SA, Austad C, Halsaa V, Hammer HB, Kvien TK, Uhlig T. Fibromyalgia in patients with rheumatoid arthritis. A 10-year follow-up study, results from the Oslo Rheumatoid Arthritis Register. Clin Exp Rheumatol. 2019;37(1):58–62.
   Web of Science ®Google Scholar
• Shresher NM, Mohamed AE, Elshahaly MH. Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis. Rheumatol Int. 2019;39(10):1703–1710. doi:10.1007/s00296-019-04403-8
   Web of Science ®Google Scholar
• Bucourt E, Martaillé V, Goupille P, et al. A comparative study of fibromyalgia, rheumatoid arthritis, spondyloarthritis, and sjögren’s syndrome; impact of the disease on quality of life, psychological adjustment, and use of coping strategies. Pain Med. 2019;:1–10.
   Web of Science ®Google Scholar
• Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis. 2018;21(3):639–646. doi:10.1111/1756-185X.13055
   PubMed Web of Science ®Google Scholar
• Duffield SJ, Miller N, Zhao S, Goodson NJ. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(8):1453–1460. doi:10.1093/rheumatology/key075.533
   PubMed Web of Science ®Google Scholar
• Salaffi F, Di Carlo M, Farah S, Di Donato E, Carotti M. Prevalence of frailty and its associated factors in patients with rheumatoid arthritis: a cross-sectional analysis. Clin Rheumatol. 2019;38(7):1823–1830. doi:10.1007/s10067-019-04486-5
   PubMed Web of Science ®Google Scholar
• Durán J, Combe B, Niu J, Rincheval N, Gaujoux-Viala C, Felson DT. The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort. Rheumatol (United Kingdom). 2015;54(12):2166–2170.
   Web of Science ®Google Scholar
• da Chakr RMS, Brenol C, Ranzolin A, et al. Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia. Rev Bras Reumatol (English Ed.) 2017;57(5):403–411.
   Google Scholar
• Puchner R, Sautner J, Gruber J, et al. High burden of sexual dysfunction in female patients with rheumatoid arthritis: results of a cross-sectional study. J Rheumatol. 2019;46(1):19–26. doi:10.3899/jrheum.171287
   Web of Science ®Google Scholar
• Josefsson KA, Gard G. Women’s experiences of sexual health when living with Rheumatoid Arthritis - An explorative qualitative study. BMC Musculoskelet Disord. 2010;11(1):240. doi:10.1186/1471-2474-11-240
   PubMed Web of Science ®Google Scholar
• Coskun B, Coskun BN, Atis G, Ergenekon E, Dilek K. Evaluation of sexual function in women with rheumatoid arthritis. Urol J. 2013;10(4):1081–1087.
   Web of Science ®Google Scholar
• El Miedany Y, El Gaafary M, El Aroussy N, Youssef S, Ahmed I. Sexual dysfunction in rheumatoid arthritis patients: arthritis and beyond. Clin Rheumatol. 2012;31(4):601–606. doi:10.1007/s10067-011-1891-2
   Web of Science ®Google Scholar
• Bay LT, Graugaard C, Nielsen DS, Möller S, Ellingsen T, Giraldi A. Sexual health and dysfunction in patients with rheumatoid arthritis: a cross-sectional single-center study. Sex Med. 2020;8(4):615–630. doi:10.1016/j.esxm.2020.07.004
   Web of Science ®Google Scholar
• Saad RB, Fazaa A, Rouached L, et al. Sexual dysfunction and its determinants in women with rheumatoid arthritis. Z Rheumatol. 2020. doi:10.1007/s00393-020-00890-4
   Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: european consensus on definition and diagnosis. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
   PubMed Web of Science ®Google Scholar
• Mochizuki T, Yano K, Ikari K, Okazaki K. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: a cross-sectional study. Geriatr Gerontol Int. 2019;19(9):907–912. doi:10.1111/ggi.13747
   PubMed Web of Science ®Google Scholar
• Giles JT, Ling SM, Ferrucci L, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Care Res. 2008;59(6):807–815. doi:10.1002/art.23719
   Web of Science ®Google Scholar
• Petermann-Rocha F, Chen M, Gray SR, Ho FK, Pell JP, Celis-Morales C. Factors associated with sarcopenia: a cross-sectional analysis using UK Biobank. Maturitas. 2020;133(12):60–67. doi:10.1016/j.maturitas.2020.01.004
   Web of Science ®Google Scholar
• Munro R, Capell H. Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann Rheum Dis. 1997;56(5):326–329. doi:10.1136/ard.56.5.326
   Web of Science ®Google Scholar
• Doğan SC, Hizmetli S, Hayta E, Kaptanoğlu E, Erselcan T, Güler E. Sarcopenia in women with rheumatoid arthritis. Eur J Rheumatol. 2015;2:57–61. doi:10.5152/eurjrheum.2015.0038
   PubMed Web of Science ®Google Scholar
• Schaap LA, Pluijm SMF, Deeg DJH, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119(6):526.e9–17. doi:10.1016/j.amjmed.2005.10.049
   Web of Science ®Google Scholar
• Andrews J, Trupin L, Yelin E, Hough C, Covinski K, Katz P. Frailty and Reduced Physical Function Go Hand in Hand in Adults with Rheumatoid Arthritis: a U.S. Observational Cohort Study. Clin Rheumatol. 2017;36(5):1031–1039.
   PubMed Web of Science ®Google Scholar
• Li G, Chen M, Li X, et al. Frailty and risk of osteoporotic fractures in patients with rheumatoid arthritis: data from the Ontario Biologics Research Initiative. Bone. 2019;127:(February):129–34. doi:10.1016/j.bone.2019.06.006
   Web of Science ®Google Scholar
• Andrews JS, Trupin L, Wysham KD, Hough CL, Yelin EH, Katz PP. The impact of frailty on changes in physical function and disease activity among adults with rheumatoid arthritis. ACR Open Rheumatol. 2019;1(6):366–372. doi:10.1002/acr2.11051
   PubMedGoogle Scholar
• Briot K, Geusens P, Em Bultink I, Lems WF, Roux C. Inflammatory diseases and bone fragility. Osteoporos Int. 2017;28(12):3301–3314. doi:10.1007/s00198-017-4189-7
   PubMed Web of Science ®Google Scholar
• Güler-Yüksel M, Btjsterbosch J, Ypm G-R, et al. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis. Ann Rheum Dis. 2008;67(6):823–828. doi:10.1136/ard.2007.073817
   PubMed Web of Science ®Google Scholar
• Amin S, Gabriel SE, Achenbach SJ, Atkinson EJ, Joseph Melton L. Are young women and men with rheumatoid arthritis at risk for fragility fractures? A population-based study. J Rheumatol. 2013;40(10):1669–1676. doi:10.3899/jrheum.121493
   PubMed Web of Science ®Google Scholar